Several studies have indicated that, while circulating FGF21 levels are elevated, its signal transduction and actions are impaired in the skeletal muscles of patients with T2DM and insulin-resistant human skeletal muscle myotubes with diet-induced obesity [35, 36]. Here, FGF21 is linked to obesity disorder.